Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. / Vilsbøll, Tina; Krarup, T; Madsbad, S; Holst, Jens Møller.

I: Diabetologia, Bind 45, Nr. 8, 01.08.2002, s. 1111-9.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Vilsbøll, T, Krarup, T, Madsbad, S & Holst, JM 2002, 'Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients', Diabetologia, bind 45, nr. 8, s. 1111-9. https://doi.org/10.1007/s00125-002-0878-6

APA

Vilsbøll, T., Krarup, T., Madsbad, S., & Holst, J. M. (2002). Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Diabetologia, 45(8), 1111-9. https://doi.org/10.1007/s00125-002-0878-6

Vancouver

Vilsbøll T, Krarup T, Madsbad S, Holst JM. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Diabetologia. 2002 aug. 1;45(8):1111-9. https://doi.org/10.1007/s00125-002-0878-6

Author

Vilsbøll, Tina ; Krarup, T ; Madsbad, S ; Holst, Jens Møller. / Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. I: Diabetologia. 2002 ; Bind 45, Nr. 8. s. 1111-9.

Bibtex

@article{3d710edf92434b11a57d0f3d2363c8ba,
title = "Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients",
abstract = "Glucagon-like-peptide-1 (GLP-1) is strongly insulinotropic in patients with Type II (non-insulin-dependent) diabetes mellitus, whereas glucose-dependent insulinotropic polypeptide (GIP) is less effective. Our investigation evaluated {"}early{"} (protocol 1) - and {"}late phase{"} (protocol 2) insulin and C-peptide responses to GLP-1 and GIP stimulation in patients with Type II diabetes.",
author = "Tina Vilsb{\o}ll and T Krarup and S Madsbad and Holst, {Jens M{\o}ller}",
year = "2002",
month = aug,
day = "1",
doi = "http://dx.doi.org/10.1007/s00125-002-0878-6",
language = "English",
volume = "45",
pages = "1111--9",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "8",

}

RIS

TY - JOUR

T1 - Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

AU - Vilsbøll, Tina

AU - Krarup, T

AU - Madsbad, S

AU - Holst, Jens Møller

PY - 2002/8/1

Y1 - 2002/8/1

N2 - Glucagon-like-peptide-1 (GLP-1) is strongly insulinotropic in patients with Type II (non-insulin-dependent) diabetes mellitus, whereas glucose-dependent insulinotropic polypeptide (GIP) is less effective. Our investigation evaluated "early" (protocol 1) - and "late phase" (protocol 2) insulin and C-peptide responses to GLP-1 and GIP stimulation in patients with Type II diabetes.

AB - Glucagon-like-peptide-1 (GLP-1) is strongly insulinotropic in patients with Type II (non-insulin-dependent) diabetes mellitus, whereas glucose-dependent insulinotropic polypeptide (GIP) is less effective. Our investigation evaluated "early" (protocol 1) - and "late phase" (protocol 2) insulin and C-peptide responses to GLP-1 and GIP stimulation in patients with Type II diabetes.

U2 - http://dx.doi.org/10.1007/s00125-002-0878-6

DO - http://dx.doi.org/10.1007/s00125-002-0878-6

M3 - Journal article

VL - 45

SP - 1111

EP - 1119

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 8

ER -

ID: 34069971